Advertisement

Lung Cancer

App Triggers Earlier Detection of Relapse, May Help Improve Survival of Patients With Lung Cancer

Web-based applications have invaded mainstream culture and grabbed the attention of multitudes of people around the world. According to a study presented at the 2016 ASCO Annual Meeting...

Pancreatic Cancer

ASCO Guideline on Potentially Curable Pancreatic Cancer

As reported in the Journal of Clinical Oncology by Alok A. Khorana, MD, and colleagues, ASCO has released a clinical practice guideline on the treatment of potentially curable pancreatic cancer...

Breast Cancer

Using Social Media to Accelerate Genomic Research

The success of using social media to push forward causes for social good was a driving factor in the launch this past October of the Metastatic Breast Cancer Project, which aims to accelerate...


Advertisement

More Top Stories

Bladder Cancer

Arjun Vasant Balar, MD, on Urothelial Carcinoma: Analysis of the IMvigor210 Cohort 1

Prostate Cancer

Novel Approach to PET/CT Imaging May Predict Location and Extent of Primary Prostate Cancer

With surgical removal at the front line of defense against prostate cancer, oncologists are considering prostate-specific molecular imaging at the point of initial biopsy and preoperative planning to root out the full extent of disease, researchers showed at the 2016 Annual Meeting of the Society...

Advertisement

Poorer Outcome in Favorable-Histology Wilms Tumor Associated With Chromosome 1q Gain Reported in U.S. Study

The Children’s Oncology Group found that chromosome 1q gain is associated with poorer event-free and overall survival in patients with favorable-histology Wilms tumor. Gratias et al reported these findings in the Journal of Clinical Oncology.

Study Details

The study involved analysis of...

Breast Cancer

Julie Lemieux, MD, on Letrozole in Postmenopausal Early-Stage Breast Cancer: Patient-Reported Outcomes

U-M Comprehensive Cancer Center Receives $17.5 Million Commitment, Will Create New Institute

The University of Michigan (U-M) Board of Regents announced a $17.5 million commitment for cancer research from Madeline and Sidney Forbes of Bloomfield Hills, Michigan. This gift will create the Forbes Institute for Cancer Discovery within the U-M Comprehensive Cancer Center.

In addition, the...

Recent Staff Announcements at Fox Chase Cancer Center

Philip A. Pancari, MD, has joined the Department of Hematology/Oncology at Fox Chase Cancer Center, providing additional physician support for the Fox Chase Cancer Center–Temple University Hospital Bone Marrow Transplant (BMT) Program.

“Having worked at Fox Chase for the past 3 years as a...

FDA Grants Breakthrough Therapy Designation for Daratumumab in Combination With Standard of Care for Multiple Myeloma

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to the immunotherapy daratumumab (Darzalex) in combination with lenalidomide (Revlimid) and dexamethasone, or bortezomib (Velcade) and dexamethasone, for the treatment of patients with multiple myeloma who have ...

Lymphoma

Fredrick B. Hagemeister, Jr, MD, on Using Rituximab Maintenance

Geriatric Oncology
Supportive Care
Leukemia

Assessment of Fitness, Function, and Quality of Life Essential in Treatment of Older Patients With CLL

Significant progress has been made in the past 2 decades in the care of patients with chronic lymphocytic leukemia (CLL). Recently, the therapeutic armamentarium has expanded for such patients with the introduction of new targeted agents.

CLL is predominantly a disease of the elderly, with a...

Advertisement

Gene-Expression Signature Assay Identifies High-Risk Stage II Colon Cancer

In an analysis reported in the Journal of Clinical Oncology, Niedzwiecki et al found that the ColDx gene-expression signature assay identified high-risk stage II colon cancer among patients in the phase III Alliance C9581 trial. This assay has been shown to be independently prognostic for...